What is the future for fluoride in the treatment of osteoporosis? J. D. RingeP. J. Meunier Editorial Pages: 71 - 74
Evaluation of therapeutic efficacy in osteoporosis S. AdamiS. OrtolaniR. Wasnich Review Article Pages: 75 - 78
A review of the recent advances in magnetic resonance imaging in the assessment of osteoporosis S. MajumdarH. K. Genant Review Article Pages: 79 - 92
Uninterrupted oral bisphosphonate (pamidronate) therapy of patients with osteoporosis is not associated with chronic stimulation of parathyroid hormone secretion J. O. LandmanS. E. Papapoulos Original Article Pages: 93 - 96
Caffeine and the calcium economy revisited M. J. Barger-LuxR. P. Heaney Original Article Pages: 97 - 102
Calciotropic hormones in elderly people with and without hip fracture C. L. BenhamouD. TourliereP. Jallet Original Article Pages: 103 - 107
Monofluorophosphate increases lumbar bone density in osteopenic patients: A double-masked randomized study J. L. SebertP. RichardG. Loeb Original Article Pages: 108 - 114
Histomorphometric analysis of iliac crest bone biopsies in placebo-treated versus fluoride-treated subjects M. W. LundyM. StaufferB. L. Riggs Original Article Pages: 115 - 129
Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass C. H. TurnerM. PeacockC. C. Johnston Jr. Original Article Pages: 130 - 135
Cost-effectiveness of fracture prevention in established osteoporosis B. JönssonC. ChristiansenJ. Hedbrandt Original Article Pages: 136 - 142